BOT 4.76% 33.0¢ botanix pharmaceuticals ltd

Ann: Phase 2a Study Shows BTX 1801 Eradicates S. Aureus, page-561

  1. 744 Posts.
    lightbulb Created with Sketch. 183
    Are you a troll by any chance? Now suggesting the product is inert? Did you read the study or results? All I can say is my partner who is an actual doctor, dermatologist and skin researcher (not a chiropractor or podietrist) was impressed with the results and looks forward to the product developing so she can use in in her skin surgeries daily.

    If you have a look at a mupirocene study here https://pubmed.ncbi.nlm.nih.gov/2516463/#:~:text=Local%20side%20effects%20such%20as,primary%20and%20secondary%20skin%20infections.
    You will see efficany at <75% eradication after treatment. The biggest issue as most have touched on is the drug resistance which in most recent studies is up to 95%. I really think false portrails of expertise are a bit of a joke. As a scientist (non medical) I can undersand the purpose and limitation of the phase 2a study, I could look that up mupirocene in about 10 seconds to run a brief compare. I suggest you ask the internet for your money back on that certificate as it appears to have limited value.

 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
33.0¢
Change
0.015(4.76%)
Mkt cap ! $597.3M
Open High Low Value Volume
32.5¢ 33.5¢ 32.3¢ $1.265M 3.862M

Buyers (Bids)

No. Vol. Price($)
4 129446 32.5¢
 

Sellers (Offers)

Price($) Vol. No.
33.0¢ 131308 2
View Market Depth
Last trade - 16.10pm 09/08/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.